Pentosan Polysulfate vs TB4-Frag (TBF)
A side-by-side research comparison of Pentosan Polysulfate and TB4-Frag (TBF) across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Pentosan Polysulfate | TB4-Frag (TBF) |
|---|---|---|
| Full name | Pentosan Polysulfate Sodium | Thymosin Beta-4 Fragment |
| Category | Healing & Recovery | Healing & Recovery |
| Status | FDA Approved | Research compound |
| Mechanism | Acts as a glycosaminoglycan analog that coats bladder mucosa, inhibits complement activation, and stimulates proteoglycan synthesis in cartilage. | Retains the actin-sequestering motif of full TB-4, promoting cell migration, angiogenesis, and reduction of inflammation at injury sites. The shorter sequence may offer improved bioavailability and targeted tissue penetration. |
| Molecular weight | 4000-6000 Da (average) | ~1,200-1,800 Da (fragment) |
| Half-life | ~24 hours | ~2-4 hours |
| Bioavailability | ~3-6% oral; higher via injection | High subcutaneous absorption |
| Typical dose | 100 mg | 200-750 mcg per dose |
| Frequency | 3x daily (oral) | Daily or every other day |
| Route | Oral or subcutaneous injection | Subcutaneous injection |
Pentosan Polysulfate reported benefits
- Bladder wall protection
- Cartilage repair support
- Anti-inflammatory action
- Joint pain reduction
TB4-Frag (TBF) reported benefits
- Wound and tissue healing
- Reduced inflammation
- Potential improved tissue penetration vs full TB-4
- Support for tendon and muscle repair
- Angiogenesis promotion
Related comparisons
Research and educational reference only. Not medical advice.